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has congenital heart disease (CHD) diagnosed, and many
(25%-35%) have critical CHD necessitating heart surgery
soon after birth. As recently as the 1960s, only 20% of
neonates with critical CHD survived to adulthood. Today,
thanks to better diagnostic technologies and methods
(including prenatal diagnosis), advances in surgery, and
improved postoperative care, early survival is greater than
90%. Coincident with improved early outcomes, there
has been a sobering recognition of the ongoing risk of late
mortality, as well as significant morbidity, for these chil-
dren. In particular, neurodevelopmental disability is now
recognized as the most common long-term complication
of critical CHD and has the most negative impact on quality
of life, academic performance, and opportunity for indepen-
dence as an adult.
Most studies of neuroprotection in the CHD population
have focused on the intraoperative period and management
of cardiopulmonary bypass. There is little evidence, howev-
er, that these strategies have yielded significant improve-
ments in neurodevelopmental outcomes. A recent analysis
of more than 1700 patients born 1996 to 2009 who under-
went cardiac surgery at younger than 9months demonstrated
only modest improvement in early neurodevelopment out-
comes since 1996, even after adjustment for patient factors.1
A systematic review of current practices for neuromonitor-
ing and neuroprotection during cardiac surgery in infants
found that the level of evidence is insufficient to support
the effectiveness of any of the currently used neuroprotective
therapies.2 These findings suggest that a new approach and
new targets for neuroprotection are essential to improve
outcomes.
Patient and environmental factors, such as prematurity,
genetic syndromes, and socioeconomic status, are likely
more important determinants of neurodevelopmental out-
comes than are operative management strategies.3-5 In
addition, there is an increasing body of evidence thatFrom the Department of Pediatric Cardiothoracic Surgery, The Children’s Hospital of
Philadelphia, Philadelphia, Pa.
Disclosures: Author has nothing to disclose with regard to commercial support.
Received for publication Sept 22, 2014; accepted for publication Sept 22, 2014.
Address for reprints: J. William Gaynor, MD, The Children’s Hospital of Philadel-
phia, Pediatric Cardiothoracic Surgery, 34th St and Civic Center Blvd, Philadel-
phia, PA 19104 (E-mail: gaynor@email.chop.edu).
J Thorac Cardiovasc Surg 2014;148:1790-1
0022-5223/$36.00
Copyright  2014 by The American Association for Thoracic Surgery
http://dx.doi.org/10.1016/j.jtcvs.2014.09.061
1790 The Journal of Thoracic and Cardiovascular Suraltered fetal hemodynamics secondary to CHD lead to
decreased blood flow or oxygen delivery to the fetal
brain, resulting in impaired brain growth and altered
structural and cellular maturation, particularly of the
white matter. Magnetic resonance imaging (MRI) studies
in CHD fetuses show smaller gestational age- and weight-
adjusted total brain volumes and abnormal brain meta-
bolism, as well as delayed cortical development and
folding.6-10 At birth, brain maturation in neonates with
hypoplastic left heart syndrome or transposition of the
great arteries is delayed by approximately 1 month
relative to a normative sample.8 Postnatal MRI studies
have shown that white matter injury is evident in as many
as 20% of infants before cardiac surgery and in 40% to
50% early in the postoperative period.11-15 Andropoulos
and colleagues4 showed that a lower brain maturity score
at birth by MRI is associated with greater brain injury in
both the preoperative and postoperative periods. Beca and
associates15 recently reported that severity of brain immatu-
rity at birth predicts the severity of neurodevelopmental
impairment at 2 years of age after cardiac surgery in
infancy. Thus altered brain development secondary to
CHD may increase vulnerability to perioperative hemody-
namic instability and hypoxic or ischemic injury. There
appear to be long-lasting consequences of this abnormal
brain development and white matter injury. For example,
von Rhein and colleagues16 showed that brain volumes
remain smaller into adolescence and that the magnitude
of reduction correlates with neurodevelopmental outcomes.
Rollins and coworkers17 recently evaluated the neurodeve-
lopmental impact of white matter injury and abnormal
white matter microstructure in adolescents with transposi-
tion of the great arteries enrolled in the Boston Circulatory
Arrest Study. They found that regional alternations in white
matter microstructure, as assessed by MRI and diffusion
tensor imaging, were correlated with performance for math-
ematics achievement, inattention, executive function, visual
and spatial skills, and memory.
Two articles in this issue of the Journal provide important
additions to the growing body of data linking CHD,
abnormal brain development, white matter injury, and the
risk of long-term neurodevelopmental disability. Heinrichs
and colleagues18 fromAachen correlated structural brain ab-
normalities identified byMRIwith neurodevelopmental out-
comes in adolescent survivors of the arterial switch
operation. Moderate to severe structural abnormalities
were found in 32% of subjects. White matter injury, charac-
terized by periventricular leukomalacia, was present in more
than 50% of subjects. Greater severity of white matter injury
correlated with worse neurodevelopment impairment.gery c November 2014
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only independent patient-related risk factors for neurologic
dysfunction, reduced intelligence, periventricular leukoma-
lacia, and reduced brain volume. Operative management
factors, including duration of deep hypothermic circulatory
arrest, were not significant predictors of outcome. Lynch and
associates19 from our group in Philadelphia provided
additional evidence that preoperative factors are important
determinants of the risk of perioperativewhite matter injury.
Novel optical imaging strategies were used to assess preop-
erative and postoperative cerebral hemodynamics in
neonates undergoing stage 1 reconstruction for hypoplastic
left heart syndrome. Consistent with previous studies, new
or worsened white matter injury was identified by MRI in
almost 50% of patients after surgery. Importantly, the risk
of acquired post-operative white matter injury was highly
correlated with longer time between birth and surgery,
whereas perioperative and postoperative variables did not
predict injury. These findings, which must be validated,
suggest that changes in cerebral hemodynamics and cerebral
oxygen metabolism after birth may be important modifiers
of the risk of perioperative white matter injury in some
neonates with CHD. Further studies are needed before it
can be concluded that strategies to modify cerebral blood
flow before surgery or altering the time of surgery will
lead to decreased brain injury and improved neurodevelop-
mental outcomes.
In summary, there is growing evidence that abnormal
brain development beginning in utero and the resultant brain
immaturity at birth are primarymajor risk factors underlying
perioperative hypoxic/ischemic white matter brain injury
and subsequent neurodevelopmental disability seen in
more than 50% of neonates after surgery for CHD. These
findings support the hypothesis that the presence of CHD
leads to a complex combination of developmental abnormal-
ities in the brain and direct brain injury secondary to hypoxia
or ischemia, especially to the developing white matter.20
Volpe20 has noted that this pattern of destructive and devel-
opmental disturbances is similar to the brain injury found in
infants born prematurely and coined the term ‘‘encephal-
opathy of CHD.’’ The current body of evidence suggests
that neuroprotective strategies initiated at the time of cardiac
surgery, although potentially important to prevent further
injury, are inadequate to improve the neurodevelopmental
outcomes significantly for these patients. To optimize brain
development, prevent brain injury, and improve neurodeve-
lopmental outcomes for these vulnerable infants, strategies
to provide neuroprotection and enhance neuroplasticity
may need to be initiated before birth.
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